Home › Funds › Liontrust Investment Partners LLP › EW

Liontrust Investment Partners LLP position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Liontrust Investment Partners LLP reported holding 1,216,379 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$110.0M, representing 1.62% of its reported portfolio and ranking #21 among its reported holdings. Liontrust Investment Partners LLP has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.22M sh
Reported value held$110.03M
Portfolio Weight1.62%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Liontrust Investment Partners LLP's EW position evolved

Liontrust Investment Partners LLP first disclosed a stake in EW in Q3 2023 at 18,650 shares (US$1.3M). The position peaked in Q4 2024 at 1,610,439 shares, worth US$119.2M. Across 12 filings, Liontrust Investment Partners LLP increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,216,379 shares valued at US$110.0M — an increase of 78,008 shares quarter over quarter.. Notable position changes include a 6746% increase in Q4 2023 (shares rose 25% over the following quarter), a 33% increase in Q4 2024 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 18.65K $1.29M New
Q4 2023 1.28M $97.35M Add
Q1 2024 1.24M $118.03M Reduce
Q2 2024 1.21M $111.60M Reduce
Q3 2024 1.21M $111.60M Hold
Q4 2024 1.61M $119.22M Add
Q1 2025 1.52M $110.04M Reduce
Q2 2025 1.43M $112.04M Reduce
Q3 2025 1.36M $105.78M Reduce
Q4 2025 1.24M $106.08M Reduce
Q1 2026 1.14M $91.16M Reduce
Q2 2026 1.22M $110.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Liontrust Investment Partners LLP held EW?

Liontrust Investment Partners LLP has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Liontrust Investment Partners LLP's current position in EW?

As of Q2 2026, Liontrust Investment Partners LLP holds 1.22M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $110.03M, representing 1.62% of its reported portfolio and ranking #21.

Has Liontrust Investment Partners LLP been buying or selling EW?

In the latest 13F filing (Q2 2026), Liontrust Investment Partners LLP increased its position in EW. The position peaked in Q4 2024 at 1.61M shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.